Back to Results
First PageMeta Content
Non-small-cell lung carcinoma / Docetaxel / Squamous-cell carcinoma / Combined small-cell lung carcinoma / Medicine / Oncology / Lung cancer


Axelar announces final data from Phase II study with AXL1717 in lung cancer STOCKHOLM, SWEDEN – December 27, 2013. Axelar AB announced today the final results from its Phase II study AXL-003 in patients with non-small
Add to Reading List

Document Date: 2014-01-10 05:03:26

Open Document

File Size: 441,09 KB

Share Result on Facebook
UPDATE